Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-07-16 Purchase |
2025-07-17 5:19 pm |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
989,812 | $52.03 | $51,499,918 | 1,730,179 (Indirect) |
View |
| 2025-05-29 Sale |
2025-05-30 5:00 pm |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
3,932 | $35.94 | $141,316 | 36,068 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
10,031 | $41.23 | $413,578 | 339,769 (Indirect Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 5:35 pm |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
1,714 | $41.23 | $70,668 | 28,882 (Indirect Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 5:35 pm |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
2,197 | $41.23 | $90,582 | 35,517 (Direct) |
View |
| 2025-03-21 Sale |
2025-03-24 5:35 pm |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
3,185 | $41.23 | $131,318 | 100,479 (Direct) |
View |
| 2025-03-17 Sale |
2025-03-18 5:35 pm |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
3,762 | $41.8 | $157,252 | 96,880 (Direct) |
View |
| 2025-03-11 Sale |
2025-03-12 7:05 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
14,435 | $42.7 | $616,349 | 309,550 (Indirect Direct) |
View |
| 2025-03-11 Sale |
2025-03-12 7:05 pm |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
3,966 | $42.67 | $169,242 | 89,664 (Direct) |
View |
| 2025-03-11 Sale |
2025-03-12 7:05 pm |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
1,388 | $42.54 | $59,050 | 20,392 (Indirect Direct) |
View |
| 2025-02-26 Purchase |
2025-02-28 5:35 pm |
CRISPR Therapeutics AG | CRSP | Greene John Director |
7,000 | $44.85 | $313,948 | 7,000 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
18,360 | $55.2 | $1,013,564 | 257,235 (Indirect Direct) |
View |
| 2025-02-19 Sale |
2025-02-19 5:35 pm |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
333 | $52.8 | $17,582 | 14,800 (Indirect Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
18,568 | $54.21 | $1,006,580 | 288,845 (Indirect Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 5:35 pm |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
11,542 | $53.67 | $619,492 | 78,705 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $55.1 | $826,565 | 267,162 (Indirect Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 5:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $55.62 | $1,668,678 | 282,162 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2025-06-10 5:31 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Morrison Briggs Director |
0 | $0 | 31,209 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:47 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:38 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Morrison Briggs Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Rommel Christian Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | Fardis Maria Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-06 5:30 pm |
N/A 2035-06-05 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
13,000 | $0 | 13,000 (Direct) |
View |
Ownership |
2025-06-06 5:20 pm |
N/A 2034-12-10 |
CRISPR Therapeutics AG | CRSP | Morrison Briggs Director |
0 | $0 | 26,000 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-03 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-03 9:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2025-05-28 Exercise |
2025-05-30 5:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
10,000 | $0 | 36,068 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,688 | $0 | 339,769 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
3,750 | $0 | 28,882 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
6,250 | $0 | 35,517 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-24 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
6,250 | $0 | 100,479 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
79,167 | $0 | 79,167 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-18 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
10,000 | $0 | 96,880 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
64,166 | $0 | 96,880 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
192,500 | $0 | 192,500 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
64,166 | $0 | 64,166 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-18 5:35 pm |
N/A 2035-03-14 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
64,166 | $0 | 64,166 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 7:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
28,250 | $0 | 309,550 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 7:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
7,750 | $0 | 89,664 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 7:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
2,834 | $0 | 20,392 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-19 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
650 | $0 | 14,800 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-19 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,250 | $0 | 288,845 (Direct) |
View |
| 2025-02-16 Exercise |
2025-02-19 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
23,825 | $0 | 78,705 (Direct) |
View |
| 2024-12-24 Exercise |
2024-12-27 5:35 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,751 | $0 | 280,913 (Direct) |
View |
| 2024-12-24 Exercise |
2024-12-27 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,751 | $16.21 | 280,913 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 5:35 pm |
N/A 2034-10-16 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
48,333 | $0 | 48,333 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 5:35 pm |
N/A 2034-10-16 |
CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer |
18,333 | $0 | 18,333 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 5:35 pm |
N/A 2034-10-16 |
CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer |
18,333 | $0 | 18,333 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 5:35 pm |
N/A 2034-10-16 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
455,000 | $0 | 455,000 (Direct) |
View |